DE121838C - - Google Patents
Info
- Publication number
- DE121838C DE121838C DENDAT121838D DE121838DA DE121838C DE 121838 C DE121838 C DE 121838C DE NDAT121838 D DENDAT121838 D DE NDAT121838D DE 121838D A DE121838D A DE 121838DA DE 121838 C DE121838 C DE 121838C
- Authority
- DE
- Germany
- Prior art keywords
- serum
- bodies
- protective
- liquid
- blood serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 10
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 description 21
- 230000001681 protective effect Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 230000003053 immunization Effects 0.000 description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000001166 ammonium sulphate Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000010297 mechanical methods and process Methods 0.000 description 2
- 230000005226 mechanical processes and functions Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE121838C true DE121838C (enrdf_load_stackoverflow) |
Family
ID=390811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT121838D Active DE121838C (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE121838C (enrdf_load_stackoverflow) |
-
0
- DE DENDAT121838D patent/DE121838C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2461439C3 (de) | Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel | |
| EP0054690B1 (de) | Natriumnitroprussid-Natriumthiosulfat-Perfusor-Kit | |
| DE19916085A1 (de) | Verfahren zur Herstellung eines antiviralen Mittels | |
| DE69010294T2 (de) | Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs. | |
| DE121838C (enrdf_load_stackoverflow) | ||
| DE2357800A1 (de) | Verfahren zur herstellung von gammaglobulin | |
| DE2262427C3 (de) | Immunostimulierendes Mittel | |
| DE2010788A1 (de) | Wasserunlösliche Substanzen mit Antigenwirkung und Verfahren zu ihrer Herstellung | |
| DE2360118A1 (de) | Vakzinen gegen ferkel-colibacillose und verfahren zu ihrer herstellung | |
| CH392780A (de) | Verfahren zur Herstellung von intravenös anwendbaren Antikörperpräparaten humanen Ursprungs | |
| DE1492243C3 (de) | Injizierbare Impfstoffe | |
| Lindblom | On the effect of lipjodol on the meninges | |
| DE1942900C3 (de) | Verfahren zur Abtrennung von L-Asparaginase aus Bakterienkulturen, danach hergestellte L-Asparaginase und diese enthaltendes therapeutisches Mittel | |
| DE238162C (enrdf_load_stackoverflow) | ||
| DE2225548A1 (de) | Intravenoes vertraegliche staupe- und hepatitisvaccine | |
| DE102007021403B4 (de) | Vollei-Zubereitung | |
| DE291625C (enrdf_load_stackoverflow) | ||
| DE925375C (de) | Verfahren zur Herstellung eines Procain-Penicillin-G-Praeparates | |
| DE3530821C2 (de) | Luprostiolhaltige Lösung | |
| DE1492018C (de) | Impfstoff zur aktiven Immunisierung in Form einer Wasser-in-Öl-Emulsion | |
| DE202015003548U1 (de) | Vollei-Zubereitung | |
| DE949520C (de) | Verfahren zum Reinigen von Luft und anderen Gasen von Keimen | |
| AT36199B (de) | Verfahren zur Herstellung von Immunisierungs- und Heilmitteln gegen Infektionskrankheiten. | |
| AT54778B (de) | Verfahren zur Gewinnung von Immunstoffen. | |
| DE268223C (enrdf_load_stackoverflow) |